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Background and Purpose: Intensity-modulated radiation therapy (IMRT) has shown its superiority to 
3D conformal radiotherapy in the treatment of prostate cancer. Different optimisation algorithms are 
available: algorithms which first optimise the fluence followed by  a sequencing (IM) and algorithms 
which involve the machine parameters directly in the optimisation process (DSS). The aim of this 
treatment planning study is to compare both of them regarding dose distribution and treatment time. 
Patients, Material and Methods: Ten consecutive patients with localized prostate cancer were enrolled 
for this planning study. The planning target volume (PTV) and the rectum volume, urinary bladder and 
femoral heads as organs at risk (OAR) were delineated. Average doses, the target dose homogeneity H, 
D5, D95, monitor units per fraction and the number of segments were evaluated. 
Results: While there is only a small difference in the mean doses at rectum and bladder, there is a 
significant advantage for the target dose homogeneity in the DSS-optimised plans compared to the IM- 
optimised ones. Differences in the monitor units (nearly 10% less for DSS) and the number of 
segments are also statistically significant and reduce the treatment time. 
Conclusion: Particularly with regard to the tumor control probability the better homogeneity of the 
DSS-optimised plans is more profitable. The shorter treatment time is an improvement regarding 
intrafractional organ motion. The DSS-optimiser results in a higher target dose homogeneity and, 
simultaneously, in a lower number of monitor units. Therefore it should be preferred for IMRT of 
prostate cancer. 
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Hintergrund und Ziel: Die intensitätsmodulierte Strahlentherapie (IMRT) hat ihre Überlegenheit 
gegenüber der 3D-konformalen Strahlentherapie  in der Behandlung des Prostatakarzinoms gezeigt. 
Verschiedene Optimierungsalgorithmen stehen zur Verfügung: Algorithmen, die erst die Fluenz 
optimieren und anschließend eine Segmentierung durchführen  und Algorithmen, die die 
Maschinenparameter direkt in den Optimierungsprozess integrieren. Das Ziel dieser Planungsstudie 
ist es, beide hinsichtlich Dosisverteilung und Bestrahlungszeit zu vergleichen. 
Patienten, Material und Methode: In die Planungsstudie wurden zehn aufeinanderfolgende 
Patienten mit lokalisiertem Prostatakarzinom eingeschlossen. Das Planungszielvolumen und als 
Risikostrukturen das Rektumvolumen, Harnblase und beide Femurköpfe wurden markiert. Die 
durchschnittliche Dosis in den Risikoorganen, die Homogenität im Zielvolumen, D5, D95, die 
Monitoreinheiten pro Fraktion und die mittlere Segmentzahl wurden ermittelt. 
Ergebnisse: Während nur ein kleiner Unterschied in der mittleren Dosis in Rektum und Blase besteht, 
findet sich ein signifikanter Vorteil bezüglich der Homogenität im Zielvolumen für die mit „Direct step and 
shoot“ optimierten Pläne gegenüber denjenigen mit Fluenzoptimierung (Tabelle2). Die Unterschiede bei 
den Monitoreinheiten (fast 10% weniger für den DSS-optimierten Plan) und der Segmentzahl sind 
ebenfalls statistisch signifikant . 
Schlussfolgerung: Insbesondere im Hinblick auf die Tumorkontrollwahrscheinlichkeit ist die größere 
Homogenität der DSS-optimierten Pläne vorteilhafter. Die kürzere Behandlungszeit stellt eine 
Verbesserung in Bezug auf intrafraktionelle Organbewegung dar. Der DSS-Optimierer führt zu einer 
besseren Homogenität im Zielvolumen bei einer reduzierten Anzahl von Monitoreinheiten. Deshalb sollte 
er für die IMRT des Prostatakarzinoms bevorzugt werden. 
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Background and Purpose  
 
Recently it has been pointed out, that over the past decade intensity-modulated radiation therapy (IMRT) 
has shown its superiority to three-dimensional conformal radiotherapy (3DCRT) in the treatment of 
prostate cancer, producing more conformal dose distributions for the target volume with minimal long-
term toxicities in the organs at risk (OAR) [7, 12, 15]. Thereby image guidance is recommended to 
reduce errors of patient setup and internal motion of the prostate [12, 19, 24,25].Different algorithms for 
the optimisation have been described. Two systematically different procedures are applied generally: the 
first begins with searching for the ideal fluence and then subsequentely creates segments for the 
multileaf collimator (MLC). The second approach involves the machine parameters in the optimisation 
process like the direct machine parameter optimisation (DMPO) or direct step and shoot (DSS) [5, 14]. 
The aim of this treatment planning study is to compare the techniques of fluence optimisation with 
sequential segmentation and direct step and shoot optimisation to determine the achievable advantages 
for prostate cancer patients. 
 
Patients, Material and Methods  
 
Between March 2006 and December 2007, ten consecutive patients with a mean age of 71 years were 
enrolled for primary EBRT for localised prostate cancer. All ten patients were immobilised in a vacuum 
mattress (BlueBAG™ BodyFIX®, Medical Intelligence) and had three-dimensional treatment planning 
with a CT slice thickness of 5 mm.  
In the treatment planning system (Oncentra® MasterPlan, V3.0 (Nucletron BV, Veenendal, Netherlands) 
the Gross-Target-Volume (GTV: prostate gland and seminal vesicules), Clinical-Target-Volume (CTV, 
5mm 3D-margin added to the GTV excluding the rectal volume), Planning-Target-Volume (PTV, 10mm 
3D-margin added to the GTV without respect to the rektum) and normal tissues were delineated in 
each slice. The delineation of the volumes of interest follows the description of Bos et al. [6]. The rectal 
volume (according Guckenberger et al. [12]) and urinary bladder as well as the femoral heads were 
delineated as organs at risk (OAR). 
The planning is accomplished using the data of a Siemens Primus® linear accelerator. This machine is 
equipped with a multileaf collimator of 29 leaf pairs. The inner 27 leaf pairs have a nominal width of 
10mm at the isocentre; the outer pairs with a nominal width of 65mm at isocentre are not used for 
intensity modulation. The beam quality is 6 MV. 
For the optimisation of the IMRT, different algorithms are used. Nucletron offers as a part of the 
optimising module both their IM (intensity modulation) optimisation software and their new module DSS 
(direct step and shoot).  
The earlier IM-optimisation software searches first for the ideal fluence for each beam, followed by the 
segmentation. Due to approximations in calculations and limitations in MLC the resulting, deliverable 
fluence will no longer be optimal [4]. The new DSS module integrates the segmentation into the 
optimisation process, using the first iterations to find a set of control points (described by the leaf 
positions and the weights of the segments) that meets the machine specific requirements. During the 
remaining iterations the leaf positions and segment weights are optimised directly [14]. No post 
processing is necessary.  
 In this planning study the average dose to PTV was close to 60 Gy in 30 fractions, representing the first 
treatment sequence before the treatment volume is shrinked to the CTV. This was done by setting the 
minimum and maximum dose volume objectives  to 59 and 64 Gy respectively. Seven equispaced 
beams were chosen, starting at a gantry angle of 0°, followed by 51°, 103°, 154°, 206°, 257° and 309°. 
To find ideal weighting schemes for the dose-volume objectives, we started in a pre-study of four 
patients with a fixed weight for the PTV of 3000, as used by Dobler et al. [10] and varied the weight for 
the bladder and rectum from 100 to 1000 and 3000. The medium value of 1000 proved to be the best for 
both algorithms.  Actually there exists no clear consensus on precise constraints [20] neither unique in 
dose nor in volume fraction [2, 6, 8, 11, 12, 20, 22]. Our relatively narrow constraints, especially for the 
rectum, should pose a challenge for the optimising algorithms. The dose-volume objectives were defined 
by the scheme in table 1.  
For the optimisation the basic conditions were : minimum field size of 4 cm², at least two open leaf pairs, 
maximum number of 60 segments and minimum 4 monitor units per segment. The tumor overlap option 
was activated. That means, that regions, which are part of the PTV as well as of an OAR are handled as 
PTV and there is no penalty in the objective function for these parts of the OAR. All calculations were 
done by pencil beam algorithm with a calculation grid spacing of 5mm. 
The number of segments and the number of monitor units (MU) per fraction, that is per 2.0 Gy single 
dose were taken into account as further parameters of plan quality. Additionally the resulting overall 
treatment times were measured, including gantry and MLC movements. 
The mean doses in the OARs and the homogeneity H and D5 and D95 in the PTV were calculated. H is 
defined as H = (D5-D95)/ DAverage  [11, 21]. D5 and D95 are defined as the dose where the cumulative 
DVH of the PTV intersects with 5% respectively 95% of the PTV.  
The student’s test (t-test) for paired samples was used to analyse whether differences between the 
results of both algorithms are significant. The zero hypothesis was, that there is no difference for the 
mean values. As level of significance α = 5% was taken. 
 
Results 
 
After the DSS- optimisation the average of the mean dose in the PTV was 60.5 Gy, for the IM- 
optimisation it was 60.1 Gy. The PTV maximum dose objective was respected in seven cases for the 
DSS- optimiser, only in two for the IM- optimiser. The PTV minimum dose could not be achieved. There 
was a clear advantage for the target dose homogeneity H in the DSS- optimised plans (10.0±2) 
compared to the IM- optimised ones (19.2±4), due to a significantly lower D95 for the IM-plan (52.5Gy 
versus 56.7 Gy). This can also be seen in figure 1, showing the dose distribution for one specific 
patient in two orthogonal slices. Table 2a lists the homogeneity in the PTV  and the mean doses in the 
different regions of interest.  
In all regions the DSS-optimiser respected the dose volume objectives better or equal than the IM-
optimiser: the lower dose volume objective for the urinary bladder (15Gy / 70%) for seven plans (DSS) 
versus three plans (IM), the upper (40 Gy / 20%) for one plan each. The lower dose volume objective 
for the rectum (15Gy / 70%) is achieved in three (DSS) versus two (IM) cases, the upper one is 
missed in every single plan. The average dose at rectum and bladder shows only a small difference. 
The femoral heads are combined taking the average of the left and the right side. The average value 
for the femoral heads is higher for the DSS- algorithm. But the set dose volume constraint is never 
exceeded and reached only in two cases of the DSS- optimiser.  
The doses, the MU per fraction, the number of segments and the treatment times are averaged in 
table 2b. The saving in time is less than a minute of more than 13 minutes treatment time. 
For all parameters of table 2, except the mean value of the rectum, the better values for the DSS-
optimiser are significant with a value of p<0.05. 
 
Discussion  
 
Both algorithms produce feasible plans, which are comparable in the average dose at the OARs. 
There is always the risk, that the set of the chosen constraints favours one of the algorithms. Also the 
inverse planning is an iterative process and there are several ways of user interaction [4]. Having 
conflicting goals, we kept the doses fixed and increased the weights for the OARs until the DVH for the 
PTV became worse in a pre-study as written above.  
The mean dose for the rectum and bladder is equal or smaller for the DSS-optimised plans but with a 
larger volume in the high dose region in most cases. Generally this refers to the parts of the organs 
which are included in the PTV and such improves the homogeneity there. The higher dose at the 
femoral heads for the DSS-optimised plans is a sign of the more effective mode of operation for the 
DSS-optimiser, although the set dose volume constraint is only reached twice and so there is no 
penalty for most of the plans. But the IM-optimiser does not exhaust the dose objective at the femoral 
heads or the other way round the violations of the other dose objectives are not sufficiently punished. 
As it has been shown earlier in the case of IMRT of the hypopharyngeal carcinoma, the resulting dose 
distribution complies better with the dose volume objective of the PTV for the DSS- optimised plan 
than for the IM- optimised one and produces a significant better homogeneity [10]. 
From the clinical point of view  there is no doubt, that the better homogeneity in the PTV has the 
potential to increase the tumor control probability, while the better fulfilment of dose volume objectives 
for the OARs reduces the probability of complications. 
The number of segments stays for both algorithms plainly below the allowed maximum number what 
reduces the time for MLC movements and is a sign for effective segmentation in both algorithms. The 
reduction of treatment time is greater for the DSS-optimised plans especially due to the reduced 
number of MU – which was also found for the hypopharyngeal carcinoma by Dobler et al. [10] - and 
that is advantageous with regard to intrafractional movements of the prostate [3, 9, 16- 19, 25, 28]. But 
otherwise it is obvious, that the reduction of treatment time is not large enough to reduce the problems 
connected to intrafractional organ motion sufficiently. This is a special problem of IMRT, because the 
treatment times in 3DCRT are clearly shorter and the intrafractional organ variability is therefore not so 
pronounced as it is in IMRT. Furthermore it is essential while in the case of the 3DCRT at a correct 
setup of the patient always the whole PTV is inside of the field, in the case of IMRT between 
segments, which should complement one another there might result an overlap or gap due to 
intrafractional movements. Interfractional movements are no particular problem of IMRT and the 
treatment accuracy can be improved by image guidance [1, 19, 23, 24, 27].  
Another aspect to be regarded is the induction of a second cancer by radiotherapy [26]. The risk of 
getting a colon cancer after radiotherapy of the prostate might be reduced by decreasing the number 
of monitor units. 
 
 
Conclusion 
 
Due to the higher target dose homogeneity of the DSS- optimised plan, the lower number of monitor 
units and segments and the lower dose to the organs at risk the algorithm with direct machine 
parameter optimisation should be preferred. The reduction of the treatment time might only be 
regarded as a first step reducing problems with intrafractional organ motion. Further reduction of the 
treatment time at equivalent or better dose distribution is an aim, which might be achieved by 
improving the basic optimisation conditions like minimum field size, minimum number of open leaf 
pairs, maximum number of segments and minimum number of monitor units per segment and 
upcoming improvements of the algorithms. Other improvements are necessary, which might be 
achieved by investigations of IMRT-techniques with reduced uncertainties with respect to PTV- and 
OAR-movement. 
 ROI Usage Type Dose level 
(Gy) 
Volume (%) Weight 
PTV Target Max. Dose 64 0 3000 
PTV Target Min. Dose 59 100 3000 
Rectum OAR Max. Dose 
Volume 
40 
15 
20 
70 
1000 
1000 
Bladder OAR Max. Dose 
Volume 
40 
15 
20 
70 
1000 
1000 
Femoral 
Heads  
OAR Max. Dose 
Volume 
50 0 300 
Table 1 
 
 
 PTV Rectum Bladder Femoral  
Heads 
 Homogeneity  
H in  
% 
D5 
in  
Gy 
 
D95 
in  
Gy 
 
DAv  
in  
Gy 
 
DAv  
in  
Gy 
 
DAv 
in  
Gy 
 
DSS 10.0 
2 
62.8  
0.54 
56.7 
1.3 
29.8  
2.9 
29.6  
4.8 
25.6  
5.3 
IM 19.2 
4 
64.0  
1.1 
52.5 
2.2 
30.1  
3.3 
30.9  
4.9 
22.0  
4.2 
Table 2a 
 
 
 Monitor units 
per fraction 
Number of 
segments 
Treatment time 
in min 
DSS 663 
73 
51 
2 
13,11 
0,63 
IM 725 
117 
53 
3 
13,89 
0,95 
Table 2b
 
 
 
 
Figure 1 a, 1b 
 
Figure 1c, 1d 
 
 
 
 
Table 1 Dose volume objectives used for both optimisation algorithms. OAR: organ at 
risk; PTV: planning target volume; ROI: region of interest 
Tabelle 1 Dosis-Volumen-Objectives, die für beide Optimierungsalgorithmen 
verwendet werden. OAR: Risikoorgan; PTV: Planungszielvolumen; ROI: „region of 
interest“ 
 
Table 2 Mittelwerte und Standardabweichung über alle zehn Patienten für 
Dosisparameter (a) und technische Parameter (b).  
Tabelle 2 Average values and standard deviation over all ten patients for dose 
parameters (a) and technical parameters (b). 
 
 
Figure 1a and 1b Dose distribution in one axial slice, left DSS-, right IM- optimised. 
Figure 1c and 1d Dose distribution in the central sagittal plane 
Abbildung 1a und 1b Dosisverteilung in einer Schicht, links DSS- rechts IM- optimiert. 
Abbildung 1c und 1d Dosisverteilung in der zentralen Sagittalebene 
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